Bacterial Infections in Children

Bacterial infections in children range from common, self-limited illness to invasive, life-threatening disease. Because the spectrum of organisms, the maturity of host defences, and the consequences of infection differ from adults, childhood bacterial infection is considered as its own clinical domain, with prevention through vaccination and judicious use of antibiotics as recurring themes.

Definition

A bacterial infection in a child is illness caused by the colonization and invasion of host tissues by pathogenic bacteria, encompassing localized infections (such as otitis media or skin infection) and invasive disease (such as bacteraemia, pneumonia, or meningitis).

Scope

This entry covers the categories of bacterial infection encountered in children, the host and microbial factors that shape susceptibility and severity, the role of immunization in reducing invasive disease, and the importance of antimicrobial stewardship. It is a reference overview and does not specify antibiotic agents, doses, or individualized treatment.

Core questions

• Which bacterial pathogens predominate at different ages in childhood, and why?
• What host factors make young children especially susceptible to invasive bacterial disease?
• How has conjugate vaccination changed the epidemiology of invasive bacterial infection?
• How can clinicians limit unnecessary antibiotic use while still treating serious infection?

Key concepts

• Colonization versus invasion
• Encapsulated bacteria and conjugate vaccines
• Invasive bacterial disease (bacteraemia, meningitis, pneumonia)
• Age-dependent pathogen spectrum
• Antimicrobial resistance
• Antimicrobial stewardship
• Community- versus hospital-acquired infection

Mechanisms

Bacteria cause disease by colonizing mucosal or skin surfaces and then, in some cases, breaching local defences to invade tissue or the bloodstream. Virulence factors - capsules, toxins, adhesins, and mechanisms of immune evasion - determine pathogenic potential, while the child's innate and adaptive immunity, mucosal integrity, and prior immunization determine susceptibility. Encapsulated organisms such as Streptococcus pneumoniae, Haemophilus influenzae type b, and Neisseria meningitidis are particularly dangerous in young children because antibody responses to polysaccharide capsules mature late; conjugate vaccines overcome this by linking capsular antigen to a carrier protein. Antibiotic exposure selects for resistant organisms, so the mechanisms of resistance and the rationale for stewardship are intrinsic to the topic.

Clinical relevance

Bacterial infections are a major cause of childhood illness and, in their invasive forms, of death; conjugate vaccines and appropriate antibiotic use have substantially changed their burden. This entry describes how these infections are categorized and understood at a reference level and is not a guide to selecting or dosing antibiotics for an individual child.

Epidemiology

Pneumonia, much of it bacterial or with a bacterial component, is among the leading infectious causes of death in children under five worldwide (Walker, 2013). The introduction of pneumococcal and Haemophilus influenzae type b conjugate vaccines markedly reduced invasive disease from these organisms in settings with high coverage. Rising antimicrobial resistance is a growing concern for the treatability of childhood bacterial infection (WHO, 2024).

History

The management of childhood bacterial infection was transformed first by the antibiotic era of the mid-twentieth century and then by conjugate vaccines from the late twentieth century, which converted several leading causes of childhood meningitis and pneumonia into largely preventable diseases. Attention has since shifted toward antimicrobial resistance and the preservation of effective therapy.

Seminal works

• bradley-2011
• walker-2013
• feigin-cherry-textbook

Frequently asked questions

Why are encapsulated bacteria especially dangerous in young children?

Infants and young children mount weak antibody responses to bacterial polysaccharide capsules, leaving them vulnerable to invasive disease from organisms like pneumococcus and Haemophilus influenzae type b; conjugate vaccines were designed to overcome this limitation.

How does immunization relate to bacterial infection in children?

Conjugate vaccines against encapsulated bacteria have sharply reduced invasive bacterial disease where coverage is high, which is why prevention through vaccination is a recurring theme alongside treatment and stewardship.